Surgical Versus Medical Treatment of Acromegaly

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acromegaly Bone Diseases Bone Diseases, Endocrine Brain Diseases Central Nervous System Diseases Endocrine System Diseases Hyperpituitarism Hypothalamic Diseases Musculoskeletal Diseases Nervous System Diseases Pituitary Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Århus University Hospital, Medical department M

Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acromegaly diagnosis
treated with Somatostatin analogues or surgery
in treatment control

Exclusion criteria

treatment with GH-antagonist
never treated
not in treatment control

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Official study title

Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2011
First posted: Oct 22, 2009
Registry last updated: Dec 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed